HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer.

Abstract
Abnormal activation of the nuclear factor-kappa B (NF-κB) signaling pathway is closely implicated in triple-negative breast cancer growth, metastasis, and tumor immune escape. In this study, the anti-cancer effects of icariin, a natural flavonol glycoside, toward breast cancer cells and the underlying mechanisms were investigated. This investigation showed that icariin selectively inhibited proliferation and triggered apoptosis in breast cancer cells in a concentration- and time-dependent manner, but exhibited little cytotoxicity in normal breast cells. Moreover, icariin induced cell apoptosis via a mitochondria-mediated pathway, as indicated by the upregulated ratio of Bax/Bcl-2 and reactive oxygen species induction. Importantly, icariin impaired the activation of the NF-κB/EMT pathway, as evidenced by upregulation of SIRT6, resulting in inhibition of migration and invasion of breast cancer cells. Additionally, oss-128167, an inhibitor of SIRT6, dramatically attenuated anti-migration and anti-invasion effects of icariin. Transcriptomic analysis verified that impairment of NF-κB led to the selective function of icariin in breast cancer cells. Notably, icariin exhibited a significant tumor growth inhibition and anti-pulmonary metastasis effect in a tumor mouse model of MDA-MB-231 and 4T1 cells by regulating the tumor immunosuppressive microenvironment. Together, these results showed that icariin could effectively trigger apoptosis and inhibit the migration of breast cancer cells via the SIRT6/NF-κB signaling pathway, suggesting that icariin might serve as a potential candidate drug for the treatment of breast cancer.
AuthorsLinjiang Song, Xian Chen, Ling Mi, Chi Liu, Shaomi Zhu, Tianlin Yang, Xiaohong Luo, Qinxiu Zhang, Hua Lu, Xin Liang
JournalCancer science (Cancer Sci) Vol. 111 Issue 11 Pg. 4242-4256 (Nov 2020) ISSN: 1349-7006 [Electronic] England
PMID32926492 (Publication Type: Journal Article)
Copyright© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Drugs, Chinese Herbal
  • Flavonoids
  • NF-kappa B
  • Reactive Oxygen Species
  • SIRT6 protein, human
  • Sirtuins
  • icariin
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Disease Models, Animal
  • Drugs, Chinese Herbal (chemistry, pharmacology)
  • Female
  • Flavonoids (chemistry, pharmacology)
  • Gene Expression Profiling
  • Humans
  • Mice
  • Mitochondria (drug effects, metabolism)
  • Models, Biological
  • NF-kappa B (metabolism)
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Oxidation-Reduction (drug effects)
  • Reactive Oxygen Species (metabolism)
  • Sirtuins (metabolism)
  • Transcription, Genetic
  • Triple Negative Breast Neoplasms (drug therapy, etiology, metabolism, pathology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: